×

Stocks Merck & Co Inc

  • NYSE_trader_worried3_200.jpg

    Investors are likely to stay uncertain in the coming week, with investors focused on Europe's sovereign credit woes in the short term, and a world with less government-induced stimulus in the long term.

  • Stocks ended a volatile week with wild swings Friday as China's surprise tightening of its lending standards rattled global markets. Techs rallied, delivering the Nasdaq its best week since early January. All three major indexes snapped a four-week losing streak.Investors, keen to play the dips, retreated to one of their safe plays — technology. The Dow snapped a four-week winning streak, while the Nasdaq had its best week since early January.

  • earnings_central_badge.jpg

    What follows is a roundup of corporate earnings reports for Tuesday, Feb. 15.

  • Stocks fell sharply on Friday as world markets were shaken over China's recent decision to tighten capital requirements for banks. Where are markets headed from this point? Bill Spiropoulos, CEO of CoreStates Capital Advisors shared his insights.

  • Markets barely edged upward on Monday as Europe debt worries continue. Where are the best places to put your money now? Greg Merlino, president and founder of Ameriway Financial Services, and Ethan Anderson, portfolio manager at Rehmann Financial, shared their market strategies.

  • Stocks opened lower Monday as worries about Europe's debt woes overshadowed a couple of earnings beats. DuPont and Alcoa were the biggest Dow decliners at the open. CIT shares jumped as former Merrill chief John Thain took the helm.

  • The Dow tried to push above 10,000 a couple times, but struggled to sustain gains above that level as investors worried the recent selloff may be the beginning of a correction. Banks and techs came on strong, while drug and retail stocks were weak.

  • Stocks snapped a two-day winning streak Wednesday after tepid reports on employment and the services sector. Pfizer, Merck and Home Depot were the biggest decliners on the Dow.

  • With the health care reform in doubt, are some pharmaceutical stocks poised to pop? Les Funtleyder, health care strategist at Miller Tabak, discussed his best stock picks.

  • Cramer makes the call on viewers' favorite stocks.

  • Stocks turned a shaky start into a full-throttle rally Tuesday as UPS delivered an encouraging earnings report, pending home sales rose and Ford reported a double-digit increase in sales.

  • Stocks pared their gains Friday, the final trading day of January, after an early boost from a trio of encouraging news on the economic front: GDP, Chicago PMI and consumer confidence.  Tech and energy stocks led decliners.

  • Markets opened mixed on Thursday. What should investors expect from stocks going forward? Ray Harrison, founder of Harrison Financial Group, and Bill Smead, CEO and CIO of Smead Capital Management, shared their investment plays.

  • merck_entrance_200.jpg

    These have been sunny days for Merck. Setting aside today’s action, the stock’s been on a pretty good tear lately hitting levels not seen in nearly two years. But the sun isn’t shining everywhere within the company.

  • Stocks rose to fresh 15-month highs Tuesday, led by health-care stocks as a key Senate-seat vote in Massachusetts today could change the course of health-care reform. Citigroup bounced back after an initial dip on disappointing results.

  • On Tuesday, the Fast Money traders were poring over results from IBM after big blue beat expectations but then sold-off in the after-market.

  • With a slew of banks set to report earnings this week, the Fast Money desk is closely watching the action in the financials. Is weakness already priced in?

  • Stocks rallied Tuesday, led by health-care stocks as a key Senate-seat vote in Massachusetts today could change the course of health-care reform. Citigroup bounced back after an initial dip on disappointing results.

  • Were you so preoccupied with tech on Thursday that you missed the important action in Pharma. If so, Pete Najarian has got you covered!

  • The Dow Jones Industrial Average is currently trading near 10,700, but Jeff Hirsch, editor at Stock Traders Almanac told investors that the index could reach 15,000 by 2011. He shared his insights.